This article needs additional citations for
verification. (March 2020) |
Company type | Public company |
---|---|
Nasdaq: PSDV ASX: PVA FWB: PV3 | |
Industry | Pharmaceuticals |
Headquarters | , |
Number of locations | 2 |
Products | Iluvien |
Website |
www |
EyePoint Pharmaceuticals, Inc. (formerly pSivida Corp.) pSivida is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ).[ citation needed] QinetiQ continues to be a strategic partner. [1] [2]
In June 2004, pSivida acquired full ownership of pSiMedica. [1] In April 2018, pSivida purchased eye products firm Icon Bioscience. [3] [4]
pSivida's Dinesh K. Nadarassan presented a poster entitled "Sustained Release of Bevacizumab (Avastin) from BioSilicon"